Home > Items where Subject is "B Substances > Cannabis product (Cannabinoids) > Cannabinol / Cannabidiol (CBD oil)"

up arrow imageUp a level
Export as
Group by: Item Type | No Grouping
Number of items at this level: 105.


Barré, Tangui and Lahaie, Emmanuel and Di Beo, Vincent and Carrieri, Patrizia and Andler, Raphaël and Nguyen-Thanh, Viêt and Beck, François (2024) Cannabidiol use in France in 2022: results from a nationwide representative sample of adults. Drug and Alcohol Review , Early online .

Moore, Andrew and Straube, Sebastian and Fisher, Emma and Eccleston, Christopher (2024) Cannabidiol (CBD) products for pain: ineffective, expensive, and with potential harms. The Journal of Pain , 25 , (4) , pp. 833-842.

Oliver, Dominic and Englund, Amir and Chesney, Edward and Chester, Lucy and Wilson, Jack and Sovi, Simina and Wigroth, Stina and Hodsoll, John and Strang, John and Murray, Robin M and Freeman, Tom P and Fusar-Poli, Paolo and McGuire, Philip (2024) Cannabidiol does not attenuate acute delta-9-tetrahydrocannabinol-induced attentional bias in healthy volunteers: a randomised, double-blind, cross-over study. Addiction , 119 , (2) , pp. 322-333.

O'Reilly, Eve and Khalifa, Karima and Cosgrave, Joanne and Azam, Haleema and Prencipe, Maria and Simpson, Jeremy C and Gallagher, William M and Perry, Antoinette S (2023) Cannabidiol inhibits the proliferation and invasiveness of prostate cancer cells. Journal of Natural Products , 86 , (9) , pp. 2151-2161.

Tort, Sera and Husein-ElAhmed, Husein (2023) Clinical question: For adults with opioid‐refractory cancer pain, what are the benefits and harms of nabiximols (tetrahydrocannabinol (THC) and cannabidiol (CBD))? Cochrane Clinical Answers .

Dai, Hongying Daisy and Subramanian, Roma and Mahroke, Avina and Wang, Ming (2023) Prevalence and factors associated with vaping cannabidiol among US adolescents. JAMA Network Open , 6 , (8) .

Johnson, Drusus A and Hogan, Megan and Marriot, Ray and Heaney, Liam M and Bailey, Stephen J and Clifford, Tom and James, Lewis J (2023) A comparison of advertised versus actual cannabidiol (CBD) content of oils, aqueous tinctures, e-liquids and drinks purchased in the UK. Journal of Cannabis Research , 5 , (1) .

Narang, Gopal and Moore, Jonathan and Wymer, Kevin and Chang, Yu-Hui and Lim, Elisabeth and Adeleye, Olufunmilola and Humphreys, Mitchell R and Stern, Karen L (2023) Effect of cannabidiol oil on post-ureteroscopy pain for urinary calculi: a randomized, double-blind, placebo-controlled trial. The Journal of urology , 209 , (4) , pp. 726-733.

Lorenzetti, Valentina and Gaillard, Alexandra and Thomson, Diny and Englund, Amir and Freeman, Tom P (2023) Effects of cannabinoids on resting state functional brain connectivity: a systematic review. Neuroscience and Biobehavioral Reviews , 145 .

Mechoulam, Raphael (2023) A delightful trip along the pathway of cannabinoid and endocannabinoid chemistry and pharmacology. Annual Review of Pharmacology and Toxicology , 63 , pp. 1-13.

Englund, Amir and Oliver, Dominic and Chesney, Edward and Chester, Lucy and Wilson, Jack and Sovi, Simina and De Micheli, Andrea and Hodsoll, John and Fusar-Poli, Paolo and Strang, John and Murray, Robin M and Freeman, Tom P and McGuire, Philip (2023) Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios. Neuropsychopharmacology , 48 , pp. 869-876.

Lawn, Will and Trinci, Katie and Mokrysz, Claire and Borissova, Anna and Ofori, Shelan and Petrilli, Kat and Bloomfield, Michael and Haniff, Zarah R and Hall, Daniel and Fernandez-Vinson, Natalia and Wang, Simiao and Englund, Amir and Chesney, Edward and Wall, Matthew B and Freeman, Tom P and Curran, H Valerie (2023) The acute effects of cannabis with and without cannabidiol in adults and adolescents: a randomised, double-blind, placebo-controlled, crossover experiment. Addiction , 118 , (7) , pp. 1282-1294.

Bhat, Tariq A and Kalathil, Suresh G and Goniewicz, Maciej L and Hutson, Alan and Thanavala, Yasmin (2023) Not all vaping is the same: differential pulmonary effects of vaping cannabidiol versus nicotine. Thorax , 78 , (9) , pp. 922-932.

Lo, Lindsay A and Christiansen, April and Eadie, Lauren and Strickland, Justin C and Kim, David D and Boivin, Michael and Barr, Alasdair M and MacCallum, Caroline A (2023) Cannabidiol-associated hepatotoxicity: a systematic review and meta-analysis. Journal of Internal Medicine , 293 , (6) , pp. 724-752.

Matheson, Justin and Bourgault, Zoe and Le Foll, Bernard (2022) Sex differences in the neuropsychiatric effects and pharmacokinetics of cannabidiol: a scoping review. Biomolecules , 12 , (10) .

Frane, Nicholas and Stapleton, Erik and Iturriaga, Cesar and Ganz, Maximillian and Rasquinha, Vijay and Duarte, Robert (2022) Cannabidiol as a treatment for arthritis and joint pain: an exploratory cross-sectional study. Journal of Cannabis Research , 4 .

Kritikos, Alexandra F and Pacula, Rosalie Liccardo (2022) Characterization of cannabis products purchased for medical use in New York state. JAMA Network Open , 5 , (8) .

O'Brien, Terence J and Berkovic, Samuel F and French, Jacqueline A and Messenheimer, John A and Sebree, Terri B and Bonn-Miller, Marcel O and Gutterman, Donna L (2022) Adjunctive transdermal cannabidiol for adults with focal epilepsy: a randomized clinical trial. JAMA Network Open , 5 , (7) .

Spindle, Tory R and Sholler, Dennis J and Cone, Edward J and Murphy, Timothy P and ElSohly, Mahmoud and Winecker, Ruth E and Flegel, Ronald R and Bonn-Miller, Marcel O and Vandrey, Ryan (2022) Cannabinoid content and label accuracy of hemp-derived topical products available online and at national retail stores. JAMA Network Open , 5 , (7) .

Edinoff, Amber N and Fort, Juliana M and Singh, Christina and Wagner, Sarah E and Rodriguez, Jessica R and Johnson, Catherine A and Cornett, Elyse M and Murnane, Kevin S and Kaye, Adam M and Kaye, Alan D (2022) Alternative options for complex, recurrent pain states using cannabinoids, psilocybin, and ketamine: a narrative review of clinical evidence. Neurology International , 14 , (2) , pp. 423-436.

O'Reilly, Eve M and Cosgrave, Joanne M and Gallagher, William M and Perry, Antoinette S (2022) Plant-derived cannabinoids as anticancer agents. Trends in Cancer , 8 , (5) , pp. 350-357.

James, Tameika R and Richards, Andrea A and Lowe, Dwight A and Reid, Walton A and Watson, Charah T and Pepple, Dagogo J (2022) The in vitro effect of delta-9-tetrahydrocannabinol and cannabidiol on whole blood viscosity, elasticity and membrane integrity. Journal of Cannabis Research , 4 .

Fearby, Nathan and Penman, Samantha and Thanos, Panayotis (2022) Effects of Δ9-Tetrahydrocannibinol (THC) on obesity at different stages of life: a literature review. International Journal of Environmental Research and Public Health , 19 , (6) .

Tumati, Shankar and Lanctôt, Krista L and Wang, RuoDing and Li, Abby and Davis, Andrew and Herrmann, Nathan (2022) Medical cannabis use among older adults in Canada: self-reported data on types and amount used, and perceived effects. Drugs & Aging , 39 , pp. 153-163.

Procaccia, Shiri and Moshe Lewitus, Gil and Lipson, Carni and Shapira, Anna and Berman, Paula and Meiri, David (2022) Cannabis for medical use: versatile plant rather than a single drug. Frontiers in Pharmacology , 12 .

McDonagh, Marian S and Morasco, Benjamin J and Wagner, Jesse and Ahmed, Azrah Y and Fu, Rongwei and Kansagara, Devan and Chou, Roger (2022) Cannabis-based products for chronic pain: a systematic review. Annals of Internal Medicine , 175 , pp. 1143-1153.

Senderovich, Helen and Wagman, Hayley and Zhang, Dennis and Vinoraj, Danusha and Waicus, Sarah (2022) The effectiveness of cannabis and cannabis derivatives in treating lower back pain in the aged population: a systematic review. Gerontology , 68 , (6) , pp. 612-624.

Towobola, Abdulazeez and Towobola, Basirat and Nair, Bosky and Makwana, Arti (2021) The ethics and management of cannabis use in pregnancy following decriminalisation and licensing for medical use: narrative review. BJPsych Bulletin , pp. 1-10.

Kancherla, Neeraj and Jeyanthi, Keerthana Mani and Abbas, Ramsha and Sathi, Thanmay Sai Charaan Reddy and Upadhyay, Amrita and Garlapati, Sameer Krishna Prasad (2021) Cannabis associated mental health effects: a review. Journal of Pharmacy & Bioallied Sciences , 13 , (Suppl 2) , S943-S946.

Crippa, José Alexandre S and Zuardi, Antonio W and Guimarães, Francisco S and Campos, Alline Cristina and de Lima Osório, Flávia and Loureiro, Sonia Regina and Dos Santos, Rafael G and Souza, José Diogo S and Ushirohira, Juliana Mayumi and Pacheco, Julia Cozar and Ferreira, Rafael Rinaldi and Mancini Costa, Karla Cristinne and Scomparin, Davi Silveira and Scarante, Franciele Franco and Pires-Dos-Santos, Isabela and Mechoulam, Raphael and Kapczinski, Flávio and Fonseca, Benedito A L and Esposito, Danillo L A and Pereira-Lima, Karina and Sen, Srijan and Andraus, Maristela Haddad and Hallak, Jaime E C (2021) Efficacy and safety of cannabidiol plus standard care vs standard care alone for the treatment of emotional exhaustion and burnout among frontline health care workers during the COVID-19 pandemic: a randomized clinical trial. JAMA Network Open , 4 , (8) , e2120603.

Anderson, Lyndsey L and Etchart, Maia G and Bahceci, Dilara and Golembiewski, Taliesin A and Arnold, Jonathon C (2021) Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrations. Scientific Reports , 11 , (14948) .

O'Neill, Aisling and Annibale, Luciano and Blest-Hopley, Grace and Wilson, Robin and Giampietro, Vincent and Bhattacharyya, Sagnik (2021) Cannabidiol modulation of hippocampal glutamate in early psychosis. Journal of Psychopharmacology , 35 , (7) , pp. 814-822.

Freeman, Tom P and Craft, Sam and Wilson, Jack and Stylianou, Stephan and ElSohly, Mahmoud and Di Forti, Marta and Lynskey, Michael T (2021) Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysis. Addiction , 116 , (5) , pp. 1000-1010.

Farrelly, Aaron M and Vlachou, Styliani and Grintzalis, Konstantinos (2021) Efficacy of phytocannabinoids in epilepsy treatment: novel approaches and recent advances. International Journal of Environmental Research and Public Health , 18 , (8) .

Gilman, Jodi M and Schmitt, William A and Wheeler, Grace and Schuster, Randi M and Klawitter, Jost and Sempio, Cristina and Evins, A Eden (2021) Research letter: Variation in cannabinoid metabolites present in the urine of adults using medical cannabis products in Massachusetts. JAMA Network Open , 4 , (4) , e215490.

Krishnan, Aditya and Chizo Agwu, Juliana and Kallappa, Chetana and Pandey, Ragesh (2021) Case report. Development of central precocious puberty following cannabinoid use for paediatric epilepsy: causal or coincidence? BMJ Case Reports , 14 , e239678.

Analakkattillam, S and Langsi, V K and Hanrahan, J P and Moore, E (2021) Comparative study of dissolution for cannabidiol in EU and US hemp oil products by HPLC. Journal of Pharmaceutical Sciences , 110 , (8) , pp. 3091-3098.

Velayudhan, Latha and McGoohan, Katie and Bhattacharyya, Sagnik (2021) Safety and tolerability of natural and synthetic cannabinoids in adults aged over 50 years: A systematic review and meta-analysis. PLoS Medicine , 18 , (3) , e1003524.

Mongeau-Pérusse, Violaine and Brissette, Suzanne and Bruneau, Julie and Conrod, Patricia and Dubreucq, Simon and Gazil, Guillaume and Stip, Emmanuel and Jutras-Aswad, Didier (2021) Cannabidiol as a treatment for craving and relapse in individuals with cocaine use disorder: a randomized placebo-controlled trial. Addiction , 116 , (9) , pp. 2431-2442.

Schlag, Anne K and Hindocha, Chandni and Zafar, Rayyan and Nutt, David J and Curran, H Valerie (2021) Cannabis based medicines and cannabis dependence: a critical review of issues and evidence. Journal of Psychopharmacology , 35 , (7) , pp. 773-785.

Morel, Alix and Lebard, Pierre and Dereux, Alexandra and Azuar, Julien and Questel, Frank and Bellivier, Frank and Marie-Claire, Cynthia and Fatséas, Mélina and Vorspan, Florence and Bloch, Vanessa (2021) Clinical trials of cannabidiol for substance use disorders: outcome measures, surrogate endpoints, and biomarkers. Frontiers in Psychiatry , 12 , p. 565617.

Jones, Éamon and Vlachou, Styliani (2020) A critical review of the role of the cannabinoid compounds Δ-tetrahydrocannabinol (Δ-THC) and cannabidiol (CBD) and their combination in multiple sclerosis treatment. Molecules , 25 , (21) .

McGregor, Iain S and Cairns, Elizabeth A and Abelev, Sarah and Cohen, Rhys and Henderson, Mat and Couch, Daniel and Arnold, Jonathon C and Gauld, Natalie (2020) Access to cannabidiol without a prescription: a cross-country comparison and analysis. International Journal of Drug Policy , 85 , p. 102935.

Millar, Sophie Anne and Maguire, Ryan Francis and Yates, Andrew Stephen and O'Sullivan, Saoirse Elizabeth (2020) Towards better delivery of cannabidiol (CBD). Pharmaceuticals , 13 , (9) .

American Heart Association Clinical Pharmacology Committee and Heart Failure and Transplantation Committee of the Council on Clinical Cardiology, Council on Basic Cardiovascular Sciences, Council on Cardiovascular and Stroke Nursing, Council on Epidemiology and Prevention; Council on Lifestyle and Cardiometabolic Health, Council on Quality of Care and Outcomes Research. Medical marijuana, recreational cannabis, and cardiovascular health. Paige II, Robert L and Allen, Larry A and Kloner, Robert A and Carriker, Colin R and Martel, Catherine and Morris, Alanna A and Piano, Mariann R and Rana, Jamal S and Saucedo, Jorge F (2020) Medical marijuana, recreational cannabis, and cardiovascular health: a scientific statement from the American Heart Association. Circulation , 142 .

Cather, Jennifer Clay and Cather, J Christian (2020) Cannabidiol primer for healthcare professionals. Baylor University Medical Center proceedings , 33 , (3) .

Hindley, Guy and Beck, Katherine and Borgan, Faith and Ginestet, Cedric E and McCutcheon, Robert and Kleinloog, Daniel and Ganesh, Suhas and Radhakrishnan, Rajiv and D'Souza, Deepak Cyril and Howes, Oliver D (2020) Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis. The Lancet Psychiatry , 7 , (4) , pp. 344-353.

Lancet Press Office. (2020) The Lancet Psychiatry: Single dose of psychoactive component in cannabis could induce psychotic, depressive, and anxiety symptoms in healthy people. EurekAlert .

Lipnik-Štangelj, Metoda and Razinger, Barbara (2020) A regulatory take on cannabis and cannabinoids for medicinal use in the European Union. Archives of Industrial Hygiene and Toxicology , 71 , (1) , pp. 12-18.

Brody, Herb (2019) Cannabis: a field in flux. Nature Outlook , 572 , (S1) .

Brown, Joshua D and Winterstein, Almut G (2019) Potential adverse drug events and drug-drug interactions with medical and consumer cannabidiol (CBD) use. Journal of Clinical Medicine , 8 , (7) .

Freeman, Tom P and Hindocha, Chandni and Green, Sebastian F and Bloomfield, Michael AP (2019) Medicinal use of cannabis based products and cannabinoids. BMJ (Clinical Research ed.) , 365 , l1141.

Bloomfield, Michael A P and Hindocha, Chandni and Green, Sebastian F and Wall, Matthew B and Lees, Rachel and Petrilli, Katherine and Costello, Harry and Olabisi Ogunbiyi, M and Bossong, Matthijs G and Freeman, Tom P (2019) The neuropsychopharmacology of cannabis: a review of human imaging studies. Pharmacology & Therapeutics , 195 , pp. 132-161.

Fennessy, Paul and Murphy, L and Crowe, S (2018) Cannabis oil in an Irish children’s critical care unit. Irish Medical Journal , 111 , (8) .

Stockings, Emily and Zagic, Dino and Campbell, Gabrielle and Weier, Megan and Hall, Wayne D and Nielsen, Suzanne and Herkes, Geoffery K and Farrell, Michael and Degenhardt, Louisa (2018) Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence. Journal of Neurology, Neurosurgery and Psychiatry , 89 , (7) .

Fischer, Benedikt and Russell, Cayley and Sabioni, Pamela and van den Brink, Wim and Le Foll, Bernard and Hall, Wayne and Rehm, Jürgen and Room, Robin (2017) Lower-risk cannabis use guidelines: a comprehensive update of evidence and recommendations. American Journal of Public Health , 107 , (8) , e1-e12.

McLoughlin, Benjamin C and Pushpa-Rajah, Jonathan A and Gillies, Donna and Rathbone, John and Variend, Hannele and Kalakouti, Eliana and Kyprianou, Katerina (2014) Cannabis and schizophrenia. Cochrane Database of Systematic Reviews , (10) .


Chou, Roger and Ahmed, Azrah Y and Bougatsos, Christina and Morasco, Benjamin J and Dana, Tracy and Fu, Rongwei (2024) Living systematic review on cannabis and other plant-based treatments for chronic pain. Rockville, MD: Agency for Healthcare Research and Quality.

Lambe, Kathryn and Teahan, Áine and Lee, Caitriona and fitzpatrick, John-Mark and Cagney, Olivia and Patje, Darren and Long, Jean (2024) The efficacy and safety of medicinal cannabis in adult populations: an evidence review. Dublin: Health Research Board.

National Poisons Information Centre. (2023) National Poisons Information Centre annual report 2022. Dublin: National Poisons Information Centre.

Forensic Science Ireland. (2023) Forensic Science Ireland annual report 2022. Dublin: Forensic Science Ireland.

Health Products Regulatory Authority. (2022) Guide to import and export licences and letters of no objection for controlled drugs (including the import of cannabis products for medical use). Dublin: Health Products Regulatory Authority.

Canadian Centre on Substance Use and Addiction. (2022) Cannabis legalization: 2021–2022 observations. Ottawa: Canadian Centre on Substance Use and Addiction.

United Kingdom. Advisory Council on the Misuse of Drugs. (2021) Consumer cannabidiol (CBD) products. London: Advisory Council on the Misuse of Drugs.

Kowalski, Katya (2021) The new leaf: beyond Brexit, countering Covid. London: Volteface.

National Institute for Health and Care Excellence. (2021) Cannabis-based medicinal products. London: NICE.

European Monitoring Centre for Drugs and Drug Addiction. (2020) Low-THC cannabis products in Europe. Luxembourg: Publications Office of the European Union.

Commission on Narcotic Drugs. (2020) WHO scheduling recommendations on cannabis and cannabis-related substances. Commission on Narcotic Drugs - reconvened sixty-third session Vienna, 2–4 December 2020. Vienna: United Nations Economic and Social Council.

PDQ Integrative, Alternative and Complementary Therapies Editorial Board. (2020) PDQ Cannabis and cannabinoids. Bethesda, MD: National Cancer Institute.

Therapeutic Goods Administration. (2020) Safety of low dose cannabidiol. ACT, Australia: Australian Government Department of Health.

Food Safety Authority. (2020) Survey: regulatory issues with hemp-based food and food supplements on the Irish market. Dublin: Food Safety Authority.

Ireland. Department of Health. (2020) Medical cannabis access programme. Dublin: Department of Health.

Ireland. Department of Health. (2020) Clinical guidance on cannabis for medical use. Dublin: Department of Health.

WHO Expert Committee on Drug Dependence. (2017) Cannabidiol (CBD) pre-review report. Agenda item 5.2. Geneva: World Health Organization.

WHO Expert Committee on Drug Dependence. (2017) 39th Expert Committee on Drug Dependence: technical documents. Geneva: World Health Organization.

Health Products Regulatory Authority. (2017) Cannabis for medical use - a scientific review. Dublin: Department of Health.

Barnes, Michael P and Barnes, Jennifer C (2016) Cannabis: the evidence for medical use. London: All-Party Parliamentary Group for Drug Policy Reform.

National Centre for Pharmacoeconomics. (2013) Delta-9-tetrahydrocannabinol (THC) /Cannabidiol (CBD) (Sativex®). Dublin: National Centre for Pharmacoeconomics.


Rutgers University Libraries. (2024) Marijuana research guide. URL: https://libguides.rutgers.edu/marijuana/introducti...

WHO Expert Committee on Drug Dependence. (2023) Expert Committee on Drug Dependence information repository. URL: https://ecddrepository.org/en


Irish College of Psychiatrists. (2021) Cannabidiol (CBD) and CBD products. Dublin: Irish College of Psychiatrists.

Irish College of Psychiatrists. (2020) The effects of cannabis on mental health. Information sheet for health professionals. Dublin: Irish College of Psychiatrists.

National Institute on Drug Abuse. (2019) DrugFacts: Marijuana as medicine. Bethesda, MD: National Institute on Drug Abuse.

Dail Debates

[Oireachtas] Dáil Éireann debate. Question 638 – Cannabis for medicinal use [CBD] [10048/24]. (05 Mar 2024)

[Oireachtas] Joint Committee on Agriculture, Food and the Marine debate. Hemp industry: discussion. (27 Apr 2022)

[Oireachtas] Dáil Éireann debate. Written answer 382 – Cannabis for medicinal use [CBD oil] [13644/22]. (10 Mar 2022)

[Oireachtas] Dail Eireann debate. Questions on promised legislation [Medicinal cannabis]. (12 Jun 2019)

[Oireachtas] Dail Eireann debate. Topical issue debate – Misuse of drugs [CBD]. (11 Jun 2019)

[Oireachtas] Dail Eireann debates. Written answer 878 - Cannabis for medicinal use [15907/18]. (17 Apr 2018)

[Oireachtas] Dail Eireann debate. Written answer 432 - Misuse of drugs [8277/17] [CBD]. (21 Feb 2017)

[Oireachtas] Dail Eireann debate. Written answer 472 - Medicinal products licensing [Cannabidiol medical marijuana] [11587/16]. (24 May 2016)


Borissova, Anya and Curmi, Alex (2022) Maudsley Learning Podcast. Interview #42: More about cannabis (with Professor Valerie Curran and Dr Will Lawn). London: Maudsley Learning Podcast.


Health Products Regulatory Authority. [HPRA] European Commission consultation on cannabidiol (CBD) used in cosmetic products. (06 Mar 2024)

Food Safety Authority of Ireland. Recall of certain batches of CBD and hemp oil products due to the presence of unsafe levels of delta‐9‐tetrahydrocannabinol (THC). (14 Jul 2022)

[thejournal.ie] , McDermott, Stephen Dozens of cannabis-derived products recalled since 2021, with newer CBD items seen as 'problematic'. (18 Feb 2022)

[thejournal.ie] , O'Faolain, Aodhan High Court challenge alleges Irish anti-drug legislation is against EU free movement of goods. (23 Dec 2021)

[Irish Examiner] , Dunphy, Liz First cannabis-based product under MCAP to be available from next month. (29 Sep 2021)

[Food Safety Authority of Ireland] Recall of various CBD food supplements due to the presence of unsafe levels of delta‐9‐tetrahydrocannabinol (THC). (27 Jul 2021)

[Medical Independent] , Reilly, Catherine Epilepsy specialists call for inclusion of purified CBD product in access programme. (04 Jun 2021)

[Food Safety Authority of Ireland] FSAI issues warning on edible products (sweets) containing cannabis. (26 Apr 2021)

[thejournal.ie] , Halpin, Hayley Provision for delivery and funding of Medicinal Cannabis Access Programme announced. (21 Jan 2021)

[thejournal.ie] , Ryan, Orla 'If we sell CBD as a 'cure-all' for everything, it will drown out what it is actually effective for'. (26 Dec 2019)

[thejournal.ie] , Finn, Christina Two medicinal cannabis products approved for use in Ireland. (03 Dec 2019)

[Irish Times] , O'Connell, Jennifer CBD: What’s the story with this legal cannabis constituent? (01 Dec 2018)

[thejournal.ie] , Duffy, Ronan Confused about CBD? Here's what you need to know about Ireland and the cannabis-based remedy. (21 Jul 2018)

This list was generated on Mon May 27 04:31:23 2024 IST.